Observational studyCardiovascular drugs and therapy2024

Third-Generation Sirolimus-Eluting Bioresorbable Tyrocore Scaffold Implantation in Patients with ST-Segment Elevation Myocardial Infarction: Baseline and 6-Month OCT and Clinical Outcomes-a FANTOM STEMI Pilot Study.

Lukasz Koltowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.